Global Health Economics Group

Global Health Economics

Group Global Health Economics - EN

The activities of the Global Health Economics Group range from conducting economic evaluations of healthcare interventions, to analyses of the markets for health products and evaluations of the impacts of health-related shocks and healthcare policies on socio-economic indicators, human behaviour and health, including mental health. The group has a specific focus on infectious diseases in low-and middle-income settings. To carry out their research, the group applies a range of econometric approaches, including quasi-experimental methods and choice models. 

Group projects

  • “Vaccine for prevention and treatment of Trypanosoma cruzi infection (CRUZIVAX)”.
  • “Fast and reliable easy-to-use diagnostics for eliminating Bilharzia in young children and mothers (FreeBILy)”.
  • “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA)”.
  • “Prevention and management tools for reducing antibiotic resistance in high prevalence settings (REVERSE)”.
  • “Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE)”.